ARCHIVES

FDA Oncology Division Director Says Goal to Make Review Process “Predictable”

This article is from The Cancer Letter archive.

Vol. 22 No. 31 | August 2, 1996

Download PDF Visit The Full Archive

Related Articles

ASCO Recommends Discussing Pharmacological Prevention

July 26, 2013

DCCP Board Okays New, Recompeting Contracts Worth $4.6 Million In ‘81

October 17, 1980

Aranesp Improved Anemia In MDS In Phase II Trial

September 30, 2005

NCA Approves Major Revision In Program Project Guidelines; Smaller, Tightly Focused Grants Seen

May 27, 1983

ASCO to Present 2013 Special Awards at Annual Meeting

May 31, 2013

SWOG Seeks NSCLC Patients For Study Of Gender Differences In Lung Cancer

October 28, 2005